Insmed (INSM) Asset Writedowns and Impairment (2011 - 2026)

Insmed's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $5.1 million for Q1 2026.

• On a quarterly basis, Asset Writedowns and Impairment rose 1.81% year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $20.8 million, a 2.57% increase from a year earlier, with the FY2025 full-year figure at $20.7 million, up 3.15% from the prior year.
• Asset Writedowns and Impairment fell to $5.1 million in Q1 2026 per INSM's latest filing, from $5.3 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $10.2 million in Q3 2023 and bottomed at $1.2 million in Q2 2023.
• The 5-year median for Asset Writedowns and Impairment is $5.0 million (2024), against an average of $4.9 million.
• Biggest YoY gain for Asset Writedowns and Impairment was 297.48% in 2024; the steepest drop was 48.24% in 2024.
• Year by year, Asset Writedowns and Impairment stood at $3.7 million in 2022, then surged by 31.0% to $4.8 million in 2023, then grew by 4.87% to $5.1 million in 2024, then grew by 5.25% to $5.3 million in 2025, then dropped by 4.07% to $5.1 million in 2026.
• Per Business Quant, the three latest INSM Asset Writedowns and Impairment figures stand at $5.1 million (Q1 2026), $5.3 million (Q4 2025), and $5.1 million (Q3 2025).